SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-016787
Filing Date
2018-06-15
Accepted
2018-06-15 17:00:28
Documents
1
Period of Report
2018-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5269
  Complete submission text file 0000899243-18-016787.txt   6920
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1250 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Issuer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INSYS THERAPEUTICS, INC 1333 SOUTH SPECTRUM BLVD, SUITE 100 CHANDLER AZ 85286
Business Address
BRENNAN DANIEL (Reporting) CIK: 0001657999 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33057 | Film No.: 18902844